NuVasive, Inc. NUVA
Set alert
At close · Aug 31
52-week range unavailable
- Open
- 40.62
- Prev close
- 39.75
- Mkt cap
- 2.26B
- Vol
- 30.59M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 39.51
- High
- 40.96
- Forward P/E
- 16.86
- Beta
- 1.07
- Short ratio
- 10.39
- Inst. own
- 112.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 2, 2023
- 50-d avg
- 40.46
- 200-d avg
- 41.49
- 1y target
- 48.73
2Y chart
Events in this range
- May 4, 2022Earnings: —; estimate 0.38; surprise —%
- Aug 3, 2022Earnings: —; estimate 0.55; surprise —%
- Nov 9, 2022Earnings: —; estimate 0.53; surprise —%
- Feb 22, 2023Earnings: —; estimate 0.49; surprise —%
- Feb 23, 2023Rating: JP Morgan · — → Neutral
- May 10, 2023Earnings: —; estimate 0.41; surprise —%
- May 11, 2023Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- May 11, 2023Rating: RBC Capital · Outperform → Outperform
- May 12, 2023Rating: Barclays · Overweight → Overweight
- May 15, 2023Rating: RBC Capital · Outperform → Outperform
- May 31, 2023Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Aug 2, 2023Earnings: —; estimate 0.56; surprise —%
Signals (94)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Aug 3, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 25, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 11, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 6, 2023 | 3 years ago |
| SMA: Bearish | Jul 5, 2023 | 3 years ago |
| SMA: Bullish | Jun 29, 2023 | 3 years ago |
| SMA: Bearish | Jun 26, 2023 | 3 years ago |
| SMA: Bullish | Jun 22, 2023 | 3 years ago |
| SMA: Bearish | Jun 20, 2023 | 3 years ago |
| SMA: Bullish | Jun 15, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 6, 2023 | 3 years ago |
| RSI: Oversold | May 24, 2023 | 3 years ago |
| SMA: Bearish | May 18, 2023 | 3 years ago |
| SMA: Bullish | May 17, 2023 | 3 years ago |
| SMA: Bearish | May 16, 2023 | 3 years ago |
| MACD: Sell Signal | May 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 18, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 13, 2023 | 3 years ago |
| SMA: Bearish | Apr 12, 2023 | 3 years ago |
| SMA: Bullish | Apr 11, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 29, 2023 | 3 years ago |
| RSI: Oversold | Mar 22, 2023 | 3 years ago |
| RSI: Oversold | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 7, 2023 | 3 years ago |
| SMA: Bullish | Mar 3, 2023 | 3 years ago |
| SMA: Bearish | Feb 24, 2023 | 3 years ago |
| SMA: Bearish | Feb 10, 2023 | 3 years ago |
| SMA: Bullish | Feb 9, 2023 | 3 years ago |
| SMA: Bearish | Feb 8, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 8, 2023 | 3 years ago |
| SMA: Bullish | Feb 7, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 2, 2023 | 3 years ago |
| RSI: Overbought | Feb 2, 2023 | 3 years ago |
| RSI: Overbought | Jan 23, 2023 | 3 years ago |
| MACD: Buy Signal | Dec 30, 2022 | 3 years ago |
| SMA: Bullish | Dec 29, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 22, 2022 | 3 years ago |
| SMA: Bearish | Dec 19, 2022 | 3 years ago |
| SMA: Bullish | Dec 8, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 25, 2022 | 3 years ago |
| RSI: Oversold | Nov 9, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Nov 2, 2022 | 3 years ago |
| SMA: Bullish | Oct 28, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 18, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 7, 2022 | 4 years ago |
| RSI: Oversold | Oct 7, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 4, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 23, 2022 | 4 years ago |
| SMA: Bearish | Sep 13, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 9, 2022 | 4 years ago |
| RSI: Oversold | Sep 6, 2022 | 4 years ago |
| RSI: Oversold | Aug 26, 2022 | 4 years ago |
| SMA: Bearish | Aug 19, 2022 | 4 years ago |
| SMA: Bullish | Aug 18, 2022 | 4 years ago |
| SMA: Bearish | Aug 17, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 17, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 11, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 9, 2022 | 4 years ago |
| SMA: Bullish | Aug 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 4, 2022 | 4 years ago |
| SMA: Bullish | Jul 26, 2022 | 4 years ago |
| MACD: Buy Signal | Jun 29, 2022 | 4 years ago |
| MACD: Sell Signal | Jun 6, 2022 | 4 years ago |
| SMA: Bearish | Jun 3, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bearish | May 19, 2022 | 4 years ago |
| SMA: Bullish | May 17, 2022 | 4 years ago |
| MACD: Buy Signal | May 17, 2022 | 4 years ago |
| SMA: Bearish | May 5, 2022 | 4 years ago |
| SMA: Bullish | May 3, 2022 | 4 years ago |
| SMA: Bearish | Apr 27, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 25, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 28, 2022 | 4 years ago |
| SMA: Bearish | Mar 21, 2022 | 4 years ago |
| SMA: Bullish | Mar 17, 2022 | 4 years ago |
| SMA: Bearish | Mar 11, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 11, 2022 | 4 years ago |
| SMA: Bullish | Feb 24, 2022 | 4 years ago |
| SMA: Bearish | Feb 17, 2022 | 4 years ago |
| SMA: Bullish | Feb 15, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 15, 2022 | 4 years ago |
| SMA: Bearish | Feb 2, 2022 | 4 years ago |
| SMA: Bullish | Feb 1, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 26, 2022 | 4 years ago |
| SMA: Bearish | Jan 25, 2022 | 4 years ago |
Key statistics
- Market cap
- 2.26B
- Enterprise value
- 3.11B
- Trailing P/E
- 107.90
- Forward P/E
- 16.86
- PEG ratio
- 1.05
- Price / sales
- 1.86
- Price / book
- 2.59
- EPS (TTM)
- 0.40
- Beta
- 1.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.66%
- Revenue (TTM)
- 1.22B
- Revenue growth
- 5.80%
- Free cash flow
- 17.42M
- Total cash
- 181.20M
- Total debt
- 1.01B
- Return on equity
- 2.40%
- Shares outstanding
- 52.45M
- Short % of float
- 16.38%
- 50-day average
- 40.46
- 200-day average
- 41.49
Analyst view
Consensus: hold
- Target (low)
- 40.00
- Target (mean)
- 48.73
- Target (high)
- 58.00
- Strong buy6
- Buy7
- Hold4
- Sell1
- Strong sell0
Next earnings
Aug 2, 2023
Expected Aug 2, 2023. Consensus EPS estimate 0.55.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 2, 2023 | Jun 1, 2023 | 0.56 | — | — | — |
| May 10, 2023 | Mar 1, 2023 | 0.41 | — | — | — |
| Feb 22, 2023 | Dec 1, 2022 | 0.49 | — | — | — |
| Nov 9, 2022 | Sep 1, 2022 | 0.53 | — | — | — |
| Aug 3, 2022 | Jun 1, 2022 | 0.55 | — | — | — |
| May 4, 2022 | Mar 1, 2022 | 0.38 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 31, 2023 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| May 15, 2023 | RBC Capital | reit | Outperform | Outperform |
| May 12, 2023 | Barclays | main | Overweight | Overweight |
| May 11, 2023 | RBC Capital | reit | Outperform | Outperform |
| May 11, 2023 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Feb 23, 2023 | JP Morgan | main | — | Neutral |
About NuVasive, Inc.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nuvasive.com
News
- Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth
- Why NuVasive (NUVA) is a Top Growth Stock for the Long-Term
- NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
- Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600
- NuVasive (NUVA) Q2 Earnings Meet Estimates, Margins Down
- NuVasive, Inc. (NUVA) Q2 2023 Earnings Call Transcript
- NuVasive (NUVA) Q2 Earnings Meet Estimates
- NuVasive Announces Second Quarter 2023 Financial Results
- Earnings Scheduled For August 2, 2023
- Radcliffe Capital Management, L.P. Acquires Stake in Portage Fintech Acquisition Corp
Your note
Sign in to keep a note on NUVA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARRY JAMES CHRISTOPHER | Chief Executive Officer | Conversion of Exercise of derivative security | Feb 28, 2023 | 72,997 |
| CALAFIORE MASSIMO | Officer | Conversion of Exercise of derivative security | Feb 28, 2022 | 7,207 |
| FARRINGTON MICHAEL | Officer | Conversion of Exercise of derivative security | Feb 28, 2023 | 3,117 |
| HARBAUGH MATTHEW K | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 28, 2023 | 10,522 |
| KADIA SIDDHARTHA | Director | Conversion of Exercise of derivative security | May 26, 2022 | 3,739 |
| NORWALK LESLIE V | Director | Conversion of Exercise of derivative security | May 31, 2022 | 3,095 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.80% | 8,809,702 | 380.23M | Mar 30, 2023 |
| Vanguard Group, Inc. (The) | 11.31% | 5,933,898 | 256.11M | Mar 30, 2023 |
| State Street Corporation | 4.09% | 2,143,319 | 92.51M | Mar 30, 2023 |
| Macquarie Group Limited | 4.08% | 2,142,030 | 92.45M | Mar 30, 2023 |
| Magnetar Financial LLC | 3.39% | 1,778,831 | 76.77M | Mar 30, 2023 |
| Dimensional Fund Advisors LP | 2.98% | 1,561,855 | 67.41M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 7.55% | 3,953,828 | 170.65M | Feb 27, 2023 |
| Vanguard Total Stock Market Index Fund | 3.01% | 1,578,100 | 68.11M | Dec 30, 2022 |
| Vanguard Small-Cap Index Fund | 2.57% | 1,343,105 | 57.97M | Dec 30, 2022 |
| iShares Russell 2000 ETF | 2.19% | 1,146,964 | 49.50M | Feb 27, 2023 |
| Thrivent Mid Cap Stock Fund | 2.16% | 1,131,437 | 48.83M | Jan 30, 2023 |
| Delaware Group Equity Fds V-Small Cap Core Fund | 1.93% | 1,012,849 | 43.71M | Nov 29, 2022 |